GLP-TZ Injectable Peptide 10mg

GLP-TZ (Tirzepatide) – Research Peptide for Glucose, Insulin, and Weight Regulation Studies

Product Usage: All products made available on this website are intended exclusively for research and development purposes and are strictly not for human consumption or therapeutic use. These products are not approved by the U.S. Food and Drug Administration (FDA), and no statements on this website have been evaluated by the FDA. The products and any information provided are not intended to diagnose, treat, cure, or prevent any disease or medical condition.

Our research-grade GLP-TZ (Tirzepatide) is a dual incretin receptor agonist being extensively studied for its powerful effects on blood glucose regulation, insulin sensitivity, and weight management. Tirzepatide activates both GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) receptors, making it a next-generation candidate in metabolic and obesity-related research.

Potential Research Benefits:

• Dual Incretin Agonism: Simultaneous activation of GLP-1 and GIP receptors may enhance glucose-dependent insulin secretion, suppress appetite, and improve metabolic outcomes.
• Weight Loss Mechanisms: Clinical and preclinical models demonstrate significant fat loss and body weight reduction in response to tirzepatide administration.
• Glycemic Control: Research shows improved insulin sensitivity, reduced HbA1c levels, and lowered postprandial glucose spikes.
• Cardiometabolic Health Support: Emerging studies point to downstream benefits for cholesterol, blood pressure, and cardiovascular biomarkers.
• Reduced Food Intake and Cravings: Central nervous system signaling via GLP-1 and GIP may help suppress appetite and improve eating behavior in metabolic models.

Clinical Research References:

• Tirzepatide has been the subject of advanced clinical trials focused on type 2 diabetes, obesity, and cardiometabolic diseases due to its dual-receptor targeting approach.

Storage and Handling:

• Store at 2–8°C (35–46°F) in a refrigerated setting.
• Protect from direct sunlight and excessive humidity.
• Once reconstituted with bacteriostatic water, refrigerate and use within 4–6 weeks for best results.

Disclaimer:

This product is intended strictly for research purposes only. Not for human consumption or therapeutic use. Researchers are responsible for ensuring compliance with applicable laws and regulations.